Publications hub
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
We’re still confirming the best location for some of our content. Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Loading...
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
- (-) Scheduling (national classification system) (157)
- (-) Regulatory compliance (8)
- (-) Alert/Advisory (3)
- Advisory bodies and committees (364)
- Prescription medicines (36)
- Advertising (25)
- In Vitro Diagnostic medical devices (IVDs) (24)
- Medicine safety (23)
- Therapeutic goods regulation (20)
- Medical devices safety (14)
- Manufacturing (11)
- Safety (11)
- Non-prescription medicines (10)
- Complementary medicines (9)
- Over the counter (OTC) medicines (8)
- COVID-19 vaccines (7)
- Listed medicines (7)
- Registered complementary medicines (7)
- COVID-19 (6)
- Medicinal cannabis hub (6)
- Assessed listed medicines (5)
- Shortages (4)
- Fees and payments (3)
- Legislation (3)
- Clinical trials (2)
- Compliance and enforcement hub (2)
- Import and export (2)
- Sunscreens (2)
- Artificial Intelligence (AI) (1)
- Australian Register of Therapeutic Goods (ARTG) (1)
- Biological medicines (1)
- Breast implant hub (1)
- Cosmetics (1)
- Disinfectants/Sterilants (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Pharmacovigilance (1)
- Prescription opioids hub (1)
- Unique Device Identification (UDI) hub (1)
Filters applied:Clear all
Search
167 result(s) found, displaying 1 to 25
-
Scheduling submissionsFind out about the public submissions on scheduling matters referred to the ACMS #47 meeting held in June 2025
-
Scheduling submissionsFind out about the public submissions on scheduling matters referred to the ACMS #47 and Joint ACMS-ACCS #40 meetings held in June 2025
-
PublicationsClarifies requirements for SAS and AP applications for healthcare practitioners to access Category 2, 3, 4 and/or 5 (i.e. Schedule 8) medicinal cannabis medicines for their patients under the age of 18 years (paediatric patients).
-
Scheduling decisions (interim)Interim decisions on proposed amendments to the Poisons Standard closing 4 April 2025
-
Scheduling decisions (interim)We have reopened the consultation on the interim decision regarding IV potassium in recognition of the broad impact of the proposed changes
-
Scheduling decisions (final)This web publication constitutes a notice for the purposes of regulations 42ZCZS of the Therapeutic Goods Regulations 1990 (the Regulations).
-
Scheduling decisions (final)This web publication constitutes a notice for the purposes of regulations 42ZCZS and 42ZCZX of the Therapeutic Goods Regulations 1990 (the Regulations).
-
Scheduling decisions (final)Publication of the decisions made by a delegate of the Secretary in relation to to nicotinic acid.
-
PublicationsThis plan outlines our compliance and education priorities for 2024-2025.
-
Scheduling decisions (final)This web publication constitutes a notice for the purposes of regulations 42ZCZS and 42ZCZX of the Therapeutic Goods Regulations 1990 (the Regulations).
-
Scheduling decisions (interim)We are seeking submissions for a consultation on the interim decisions for IV potassium salts and nicotinic acid.
-
Scheduling submissionsFind out about the public submissions on interim decisions for scheduling matters referred to the ACMS #44, ACCS #38 and Joint ACMS-ACCS #36 meetings held in March 2024
-
Scheduling decisions (final)This web publication constitutes a notice for the purposes of regulations 42ZCZS and 42ZCZX of the Therapeutic Goods Regulations 1990 (the Regulations).
-
Scheduling decisions (final)Publication of the decisions made by a delegate of the Secretary in relation to glycopyrronium and palmitoylethanolamide.
-
Scheduling decisions (interim)Interim decisions on proposed amendments to the Poisons Standard closing 18 October 2024.
-
Scheduling decisions (final)This publication is a notice of decision made by a delegate of the Secretary of the Department of Health and Aged Care under regulation 42ZCZX of the Therapeutic Goods Regulations 1990, and the reasons for the decision.
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closing date: 23 August 2024
-
Scheduling submissionsFind out about the public submissions on scheduling matters referred to the ACMS #44, ACCS #38 and Joint ACMS-ACCS #36 meetings held in March 2024
-
PublicationsThis fact sheet is for healthcare practitioners to help understand the rules surrounding importation of cosmetic injectables.
-
Scheduling decisions (final)This publication is a notice of decision made by a delegate of the Secretary of the Department of Health and Aged Care under section 52D(2) of the Therapeutic Goods Act 1989, and the reasons for the decision.
-
Scheduling decisions (final)Read our notice of final decision to amend (or not amend) the current Poisons Standard
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closing date: 17 April 2024
-
Scheduling decisions (final)Final decision on proposed amendments to the Poisons Standard relating to palovarotene
-
Scheduling decisions (final)Read our notice of final decision to amend (or not amend) the current Poisons Standard in relation to bisacodyl, olopatadine and ibotenic acid.
-
Scheduling submissionsFind out about the public submissions on interim decisions for scheduling matters referred to the ACMS #42 and Joint ACMS-ACCS #34 meetings held in June 2023.